Double-blind Parallel Comparison of Three Dosages of Sertraline and Placebo in Outpatients With Obsessive-compulsive Disorder
Archives of General PsychiatryPublished 1 April 1995
John H. Greist
Citations241
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Results support the safety and efficacy of daily dosages of 50, 100, and 200 mg of sertraline in the short-term treatment of patients with OCD.
Abstract
Results support the safety and efficacy of daily dosages of 50, 100, and 200 mg of sertraline in the short-term treatment of patients with OCD.
Keywords
PsychologyNeuroscience
Archives of General PsychiatryThe Yale-Brown Obsessive Compulsive Scale
7,464 Citations1989Wayne K. Goodman
In a study involving four raters and 40 patients with obsessive-compulsive disorder at various stages of treatment, interrater reliability for the total Yale-Brown Scale score and each of the 10 individual items was excellent, with high degree of internal consistency among all item scores demonstrated with Cronbach's alpha coefficient.
Archives of General PsychiatryThe Yale-Brown Obsessive Compulsive Scale
2,749 Citations1989Wayne K. Goodman
Results from a previously reported placebo-controlled trial of fluvoxamine in 42 patients with obsessive-compulsive disorder showed that the Yale- Brown Scale was sensitive to drug-induced changes and that reductions in Yale-Brown Scale scores specifically reflected improvement in obsessive- compulsive disorder symptoms.
Archives of General PsychiatrySix-Month Prevalence of Psychiatric Disorders in Three Communities
1,597 Citations1984Jerome K. Myers
Six-month prevalence rates for selected DSM-III psychiatric disorders are reported based on community surveys in New Haven, Conn, Baltimore, and St Louis based on data gathered on more than 9,000 adults using the Diagnostic Interview Schedule.
Archives of General PsychiatryThe Epidemiology of Obsessive-Compulsive Disorder in Five US Communities
1,349 Citations1988Marvin Karno
The prevalence of obsessive-compulsive disorder was measured in five US communities among more than 18,500 persons in residential settings as part of the National Institute of Mental Health--sponsored Epidemiologic Catchment Area program, finding rates about 25 to 60 times greater than had been estimated on the basis of previous studies of clinical populations.
Archives of General PsychiatryClomipramine Treatment of Obsessive-Compulsive Disorder
494 Citations1980Peter Thorén
Clomipramine, but not nortriptyline, was superior to placebo in interview-based ratings of severity of OCD, and the effect was not clear-cut until after five weeks of treatment.
Archives of General PsychiatryClomipramine Treatment of Childhood Obsessive-Compulsive Disorder
470 Citations1985Martine F. Flament
There was a significant improvement in observed and self-reported obsessions and compulsions that was independent of the presence of depressive symptoms at baseline and the treatment seems to be independent of an antidepressant effect.
The British Journal of PsychiatryClomipramine and Exposure for Obsessive-Compulsive Rituals: 1
449 Citations1980I. M. Marks, R. S. Stern +3 more
Clomipramine is useful for compulsive ritualizers with depressed mood, but may need continuation for over a year and combination with exposure in vivo, which remains the treatment of choice for rituals without depressed mood.
Archives of General PsychiatryEfficacy of Fluvoxamine in Obsessive-Compulsive Disorder
390 Citations1989Wayne K. Goodman
A six- to eight-week double-blind placebo-controlled trial of the potent and selective serotonin reuptake inhibitor fluvoxamine was conducted in 42 patients with primary obsessive-compulsive disorder, lending partial support to the serotonin hypothesis of OCD.
Archives of General PsychiatryClomipramine in the Treatment of Patients With Obsessive-Compulsive Disorder
390 Citations1991
Clomipramine was generally well tolerated and was effective in reducing obsessive and compulsive symptoms and was superior on the basis of the physicians' and patients' evaluations of global therapeutic change.
Archives of General PsychiatryTreatment of Obsessive-Compulsive Disorder With Clomipramine and Desipramine in Children and Adolescents
369 Citations1989Henrietta L. Leonard
The specificity of the antiobsessional effect of clomipramine and the need for maintenance treatment is documented, and age at onset, duration and severity of illness, type of symptom, and plasma drug concentrations did not predict clinical response.
Journal of the American Academy of Child & Adolescent PsychiatryDouble-Blind, Crossover Trial of Fluoxetine and Placebo in Children and Adolescents with Obsessive-Compulsive Disorder
346 Citations1992Mark A. Riddle, Lawrence David Scahill +7 more
The results suggest that fluoxetine is a generally safe and effective short-term treatment for children with OCD.
Archives of General PsychiatrySpecificity of Serotonin Reuptake Inhibitors in the Treatment of Obsessive-Compulsive Disorder
311 Citations1990Wayne K. Goodman
It is hypothesized that the mechanism of action of serotonin reuptake inhibitors in obsessive-compulsive disorder may be related to chronic treatment-induced adaptive changes in presynaptic serotonin receptor function and/or indirect influences on dopaminergic function (eg, in the basal ganglia).
Current clinical practiceObsessive Compulsive Disorder
306 Citations2022Robert Hudak, Jessica M. Gannon
American Journal of PsychiatryReturn of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder
303 Citations1988Michele T. Pato, Rachel C. Zohar-Kadouch +2 more
Treatment duration before discontinuation of clomipramine was not related to the frequency or severity of obsessive-compulsive or depressive symptom appearance, suggesting that prolonged drug treatment may be warranted for obsessive-Compulsive disorder.
The British Journal of PsychiatryClomipramine, Self-exposure and Therapist-aided Exposure for Obsessive–Compulsive Rituals
261 Citations1988I. M. Marks, Paul Lelliott +5 more
It is concluded that of the three therapeutic factors tested, self-exposure was the most potent; clomipramine played a limited adjuvant role, and therapist-aided exposure a marginal one.
The British Journal of PsychiatrySertraline in the Prevention of Depression
246 Citations1992D.P. Doogan, Vincent Caillard
The study provides evidence that sertraline prevents relapse of the index episode of depression as well as recurrence of further episodes and has few side-effects.
Archives of General PsychiatryA Double-blind Desipramine Substitution During Long-term Clomipramine Treatment in Children and Adolescents With Obsessive-Compulsive Disorder
229 Citations1991Henrietta L. Leonard
Even patients receiving maintenance clomipramine treatment throughout the entire study had continued obsessive-compulsive symptoms, which varied in severity over time.
Archives of General PsychiatryControlled Comparisons of Clomipramine and Fluoxetine in the Treatment of Obsessive-Compulsive Disorder
221 Citations1990Teresa A. Pigott
Fluoxetine may represent a viable alternative to clomipramine in the treatment of obsessive-compulsive disorder, although further studies with larger sample sizes are needed.
American Journal of PsychiatryFluvoxamine treatment of obsessive-compulsive disorder
213 Citations1987Teri Perse, John H. Greist +3 more
Fluvoxamine treatment was associated with significant improvement on measures of obsessive-compulsive symptoms, anxiety, and depression, and depressed subjects' improvement on obsessive-Compulsive measures correlated with improvement in symptoms of depression.
International Clinical PsychopharmacologyA Controlled Study of Fluvoxamine and Exposure in Obsessive-Compulsive Disorder
204 Citations1990Jean Cottraux, Evelyne Mollard +6 more
All three groups improved in rituals and depression from week 0 to week 24 and 48, with a slight but non-significant superiority for combined treatment up to week24, and the drug superiority was short-lived.
PubMedResults of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.
136 Citations1990G Chouinard, Wayne K. Goodman +7 more
Results of the Y-BOCS total score, the NIMH score, and the global severity and improvement scores demonstrated a statistically significant superiority of sertraline compared with placebo.
Psychiatry ResearchClomipramine and imipramine in obsessive-compulsive disorder
122 Citations1985Jan Volavka, Fugen Neziroglu +1 more
The effect of CLI and IMI on OCD was independent of the initial severity of depression, and analyses accounting for the differences in the baseline levels indicated a somewhat superior effect ofcli over IMI over imipramine on OCD as well as depression.
Psychiatric Clinics of North AmericaNeurosurgical Treatment of Malignant Obsessive Compulsive Disorder
97 Citations1992Per Mindus, Michael A. Jenike
The selection guidelines, indications and contraindications, available procedures, probable outcome, hazards involved, preoperative work-up, and the rationale behind neurosurgery in OCD are reviewed.
Journal of Clinical PsychopharmacologySustained Plasma Concentrations of Fluoxetine and/or Norfluoxetine Four and Eight Weeks After Fluoxetine Discontinuation
86 Citations1991Michele T. Pato, Dennis L. Murphy +1 more
Journal of Clinical PsychopharmacologyClomipramine versus Fluoxetine in Obsessive-Compulsive Disorder: A Retrospective Comparison of Side Effects and Efficacy
77 Citations1990Michael A. Jenike, Lee Baer +1 more
A meta-analysis of previous studies performed in an attempt to gain some information about comparable efficacy and side effects of these two commonly used agents for the treatment of patients with obsessive-compulsive disorder.
American Journal of Occupational TherapyAnxiety and Its Treatment: Help Is Available
11 Citations1989Katherine A. Burson
One that the authors will refer to break the boredom in reading is choosing anxiety and its treatment help is available as the reading material.